TSB Regenerative Medicine Calls go live

The two Technology Strategy Board regenerative medicine competitions, which we anticipate last month, have now gone live.

A link to the Developing Therapeutics competition may be found here.

A link to the Tools & Technologies competition may be found here.  

To discuss this matter further, contact Julian Hitchcock

 
The Epigenetic Advance: CellCentric Licences Novel Discovery Programme to Takeda

CellCentric, the world-leading epigenetics company based in Cambridge UK, has announced details of a significant deal, which takes epigenetic science closer towards clinical application and commercialisation in the field of cancer.  The company has a considerable IP resource in novel epigenetic targets.  It is from this portfolio that CellCentric has granted to Takeda Pharmaceutical Company Limited an exclusive licence to develop a key cancer programme. More details here.
 

© 2010 East of England Stem Cell Network | Disclaimer and Privacy Policy